共 36 条
[21]
A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer
[J].
BMC CLINICAL PATHOLOGY,
2013, 13
[25]
Lakhani S.R., WHO Classification of Tumours of the Breast, VFourth
[30]
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
[J].
BMC CANCER,
2011, 11